Aurora Investment Counsel Amgen Inc Transaction History

Aurora Investment Counsel

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $4,614 - $5,134	-20 Reduced 0.55%	3,641 $880,000
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $4,614 - $5,134	20 Added 0.55%	3,661 $891,000
Q1 2022 May 23, 2022	BUY	$219.27 - $242.57 $26,531 - $29,350	121 Added 3.44%	3,641 $880,000
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $41,565 - $47,568	-209 Reduced 5.6%	3,520 $792,000
Q3 2021 Nov 17, 2021	BUY	$212.27 - $248.7 $13,797 - $16,165	65 Added 1.77%	3,729 $793,000
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $5,605 - $6,219	24 Added 0.66%	3,664 $893,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $807,752 - $941,304	3,640 New	3,640 $906,000

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Aurora Investment Counsel, based on Form 13F filings with the SEC.

Stay updated on Aurora Investment Counsel with notifications on news.